Sunpasitthiprasong Hospital is the main hospital of Ubon Ratchathani Province, Thailand, and is classified under the Ministry of Public Health as a regional hospital.

There are 1,188 beds in Sunpasitthiprasong Hospital.

During the past decade, Sunpasitthiprasong Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sunpasitthiprasong Hospital" #1 sponsor was "University of Oxford" with 5 trials, followed by "Rajavithi Hospital" with 2 trials sponsored, "Medigen Vaccine Biologics Corp." with 1 trials sponsored, "Newron Pharmaceuticals SPA" with 1 trials sponsored and "PT Kalbe Genexine Biologics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sunpasitthiprasong Hospital" #1 collaborator was "Mahidol Oxford Tropical Medicine Research Unit" with 3 trials as a collaborator, "Sanpasitthiprasong Hospital" with 2 trials as a collaborator, "Department for International Development, United Kingdom" with 1 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Sunpasitthiprasong Hospital" are "Sepsis" (2 trials), "AIDS" (1 trials), "Anaemia Associated With Chronic Kidney Disease" (1 trials), "COVID-19 Vaccine" (1 trials) and "Cervical Dystonia" (1 trials). Many other conditions were trialed in "Sunpasitthiprasong Hospital" in a lesser frequency.

Most popular intervention types in "Sunpasitthiprasong Hospital" are "Drug" (5 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AZD1222" (1 trials), "An educational programme for prevention of melioidosis" (1 trials), "Collect data on clinical history" (1 trials), "Dysport (R)" (1 trials) and "Highly Active Antiretroviral Treatment (combination of :NRTI, NNRTI,or PI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sunpasitthiprasong Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Sunpasitthiprasong Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sunpasitthiprasong Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sunpasitthiprasong Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".